AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8563674 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 27
Study 2694343 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone (7.5 mg/kg/day for 5 days)
Number of subjects: 125
Study 2694343 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (8 mg/40 mg/kg/day for 5 days)
Number of subjects: 125
Study 2694343 — intervention group
Group type: COMPARATOR
Intervention: Control (no antimicrobials)
Number of subjects: 125
Study 2694343 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone
Number of subjects: 125
Study 2694343 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 125
Study 2694343 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 125
Study 38261 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam (40 mg daily, increased to 80 mg daily by day 3 if well tolerated)
Number of subjects: 190
Study 38261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 31676280 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (CMT)
Number of subjects: 5
Study 31676280 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical cystectomy (RC)
Number of subjects: 5
Study 30937600 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (6 weeks of moderate-intensity walking and resistance exercise)
Number of subjects: 293
Study 30937600 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (control group)
Number of subjects: 293
Study 28272220 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin + Duloxetine (4mg + 30mg, increased to 60mg after 1 week)
Number of subjects: 150
Study 28272220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline + Doxazosin (4mg + 50mg)
Number of subjects: 150
Study 28272220 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin (4mg)
Number of subjects: 150
Study 26299324 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus followed by 1.5 mg/kg/h continuous infusion)
Number of subjects: 30
Study 26299324 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 30
Study 26299324 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 30
Study 24060577 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy with detectable circulating tumor cells (CTCs)
Number of subjects: 51
Study 24060577 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant therapy without detectable circulating tumor cells (CTCs)
Number of subjects: 51
Study 24060577 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with detectable HER2-positive CTCs prior to surgery
Number of subjects: 51
Study 21119518 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow inhalational anaesthesia (1 l min(‐1) O2 + 0.5 l min(‐1) N2O + desflurane)
Number of subjects: 50
Study 21119518 — intervention group
Group type: COMPARATOR
Intervention: High-flow inhalational anaesthesia (3 l min(‐1) O2 + 1.5 l min(‐1) N2O + desflurane)
Number of subjects: 50
Study 21119518 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 19702485 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 14
Study 19702485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 17341377 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass fiber and zircon post (Fibio) and composite resin (Durafil) core
Number of subjects: 12
Study 17341377 — intervention group
Group type: COMPARATOR
Intervention: Nickel‐chromium (NiCr) cast post and core
Number of subjects: 12
Study 15007518 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling
Number of subjects: 63
Study 15007518 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive group therapy
Number of subjects: 63
Study 15007518 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (Control)
Number of subjects: 63
Study 11471630 — intervention group
Group type: EXPERIMENTAL
Intervention: Forensic evaluation model
Number of subjects: 147
Study 11471630 — intervention group
Group type: EXPERIMENTAL
Intervention: Forensic evaluation procedure
Number of subjects: 147
Study 18069178 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% w/w minocycline gel (Dentomycin)
Number of subjects: 22
Study 18069178 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (control)
Number of subjects: 22
Study 7967807 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback gait training (BFB group)
Number of subjects: 0
Study 7967807 — intervention group
Group type: COMPARATOR
Intervention: Traditional gait training without biofeedback (reference group)
Number of subjects: 0
Study 3068174 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter change over guidewire (group I)
Number of subjects: 146
Study 3068174 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement by a new contralateral venipuncture (group II)
Number of subjects: 146
Study 3068174 — intervention group
Group type: COMPARATOR
Intervention: Control group (group III) requiring only one catheterization
Number of subjects: 146
Study 31901439 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-dieting intervention
Number of subjects: 94
Study 31901439 — intervention group
Group type: COMPARATOR
Intervention: Brochure control
Number of subjects: 94
Study 29998359 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular blocker (NM) group
Number of subjects: 112
Study 29998359 — intervention group
Group type: COMPARATOR
Intervention: Non-neuromuscular blocker (non-NM) group
Number of subjects: 112
Study 27368430 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) to 33.5 °C
Number of subjects: 92
Study 27368430 — intervention group
Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 92
Study 27368430 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH)
Number of subjects: 92
Study 27368430 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotropic support
Number of subjects: 92
Study 26556688 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 450
Study 26556688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 22984174 — intervention group
Group type: EXPERIMENTAL
Intervention: 2010 ACR/EULAR classification criteria
Number of subjects: 303
Study 22984174 — intervention group
Group type: COMPARATOR
Intervention: 1987 classification criteria
Number of subjects: 303
Study 20592389 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC (500/100/500)-docetaxel (100)
Number of subjects: 2669
Study 20592389 — intervention group
Group type: COMPARATOR
Intervention: FEC (500/100/500)-docetaxel/gemcitabine (75/2000)
Number of subjects: 2669
Study 18463891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride drink with 1 mmol/l sodium concentration
Number of subjects: 8
Study 18463891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride drink with 31 mmol/l sodium concentration
Number of subjects: 8
Study 18463891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride drink with 40 mmol/l sodium concentration
Number of subjects: 8
Study 18463891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride drink with 50 mmol/l sodium concentration
Number of subjects: 8
Study 18463891 — intervention group
Group type: COMPARATOR
Intervention: Sodium-free drink (control)
Number of subjects: 8
Study 17138196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.3 mg) and postoperative PCA intravenous morphine
Number of subjects: 52
Study 17138196 — intervention group
Group type: COMPARATOR
Intervention: Control group (PCA alone)
Number of subjects: 52
Study 14627850 — intervention group
Group type: EXPERIMENTAL
Intervention: Coralline hydroxyapatite implants
Number of subjects: 38
Study 14627850 — intervention group
Group type: COMPARATOR
Intervention: High density porous polyethylene (Medpore) implants
Number of subjects: 38
Study 10749346 — intervention group
Group type: EXPERIMENTAL
Intervention: CARTO nonfluoroscopic three-dimensional mapping system
Number of subjects: 79
Study 10749346 — intervention group
Group type: COMPARATOR
Intervention: Conventional mapping technique
Number of subjects: 79
Study 8873540 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 12
Study 8873540 — intervention group
Group type: COMPARATOR
Intervention: Placebo (flumazenil vehicle)
Number of subjects: 12
Study 8873540 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 12
Study 8873540 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 12
Study 1567097 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based consultation in addition to usual care (N=46)
Number of subjects: 101
Study 1567097 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (N=55)
Number of subjects: 101
Study 1567097 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based consultation (N=46)
Number of subjects: 101
Study 1567097 — intervention group
Group type: COMPARATOR
Intervention: Usual care (N=55)
Number of subjects: 101
Study 3929402 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (Mefoxin; MSD)
Number of subjects: 97
Study 3929402 — intervention group
Group type: EXPERIMENTAL
Intervention: MPT (metronidazole, penicillin and tobramycin)
Number of subjects: 97
Study 3929402 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 97
Study 3929402 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorectal surgery
Number of subjects: 97
Study 3929402 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliary surgery
Number of subjects: 97
Study 30916654 — intervention group
Group type: EXPERIMENTAL
Intervention: Health system websites
Number of subjects: 140
Study 29669039 — intervention group
Group type: COMPARATOR
Intervention: Sanitation
Number of subjects: 6694
Study 29669039 — intervention group
Group type: COMPARATOR
Intervention: Handwashing
Number of subjects: 6694
Study 29669039 — intervention group
Group type: COMPARATOR
Intervention: WSH (Water, Sanitation, Handwashing)
Number of subjects: 6694
Study 29669039 — intervention group
Group type: COMPARATOR
Intervention: Nutrition plus WSH (N+WSH)
Number of subjects: 6694
Study 29669039 — intervention group
Group type: COMPARATOR
Intervention: Chlorinated drinking water
Number of subjects: 6694
Study 29669039 — intervention group
Group type: COMPARATOR
Intervention: Nutrition interventions
Number of subjects: 6694
Study 29669039 — intervention group
Group type: COMPARATOR
Intervention: Combined WSH interventions
Number of subjects: 6694
Study 27098822 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin plus meropenem combination therapy
Number of subjects: 360
Study 27098822 — intervention group
Group type: COMPARATOR
Intervention: Colistin monotherapy
Number of subjects: 360
Study 23479192 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV prevention intervention
Number of subjects: 254
Study 23479192 — intervention group
Group type: EXPERIMENTAL
Intervention: History of abuse
Number of subjects: 254
Study 23479192 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner communication frequency scores
Number of subjects: 254
Study 22682898 — intervention group
Group type: EXPERIMENTAL
Intervention: Denufosol (60 mg via inhalation three times daily)
Number of subjects: 466
Study 22682898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 466
Study 22682898 — intervention group
Group type: EXPERIMENTAL
Intervention: Denufosol
Number of subjects: 466
Study 20679620 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinblastine (6 mg/m²) during each chemotherapy course followed by weekly vinblastine for a total of 1 year
Number of subjects: 217
Study 20679620 — intervention group
Group type: COMPARATOR
Intervention: No vinblastine
Number of subjects: 217
Study 20679620 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinblastine
Number of subjects: 217
Study 17880718 — intervention group
Group type: EXPERIMENTAL
Intervention: Local corticosteroid injections
Number of subjects: 150
Study 17880718 — intervention group
Group type: COMPARATOR
Intervention: Usual care (analgesics as needed)
Number of subjects: 150
Study 17880718 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost effectiveness of corticosteroid injection therapy
Number of subjects: 150
Study 16141015 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox-driven albuterol therapy
Number of subjects: 160
Study 16141015 — intervention group
Group type: COMPARATOR
Intervention: O(2) group
Number of subjects: 160
Study 12126069 — intervention group
Group type: EXPERIMENTAL
Intervention: Onion juice
Number of subjects: 38
Study 12126069 — intervention group
Group type: COMPARATOR
Intervention: Tap water (control)
Number of subjects: 38
Study 10080332 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerokeratoplasty
Number of subjects: 20
Study 10080332 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic penetrating keratoplasty
Number of subjects: 20
Study 7745800 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml of 4% lidocaine HCl
Number of subjects: 10
Study 7745800 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of nicardipine HCl + 5 ml of distilled water
Number of subjects: 10
Study 7745800 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of verapamil HCl + 5 ml of distilled water
Number of subjects: 10
Study 7745800 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of diltiazem HCl + 5 ml of distilled water
Number of subjects: 10
Study 2134114 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (initial dose 15 mg, mean final dose 22.2 mg)
Number of subjects: 26
Study 2134114 — intervention group
Group type: COMPARATOR
Intervention: Oxazepam (initial dose 45 mg, mean final dose 55.8 mg)
Number of subjects: 26
Study 2134114 — intervention group
Group type: COMPARATOR
Intervention: Buspirone and Oxazepam (both groups)
Number of subjects: 26
Study 6776571 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (S) condition
Number of subjects: 28
Study 6776571 — intervention group
Group type: COMPARATOR
Intervention: Non-Smoking (NS) condition
Number of subjects: 28
Study 31900166 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (6 mg/kg)
Number of subjects: 18
Study 31900166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 29890542 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine administration (25g) with glucose infusion
Number of subjects: 10
Study 29890542 — intervention group
Group type: COMPARATOR
Intervention: Control (250ml water with glucose infusion)
Number of subjects: 10
Study 28220582 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping bandage applied on vertebral regions corresponding to uterine dermatomes (T10 to L1 and S2 to S4)
Number of subjects: 60
Study 28220582 — intervention group
Group type: COMPARATOR
Intervention: Bandage application away from uterine dermatomes (T1 to T4)
Number of subjects: 60
Study 28220582 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping bandage
Number of subjects: 60
Study 27259300 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of Tirofiban and Fondaparinux
Number of subjects: 0
Study 27259300 — intervention group
Group type: COMPARATOR
Intervention: Fondaparinux
Number of subjects: 0
Study 27259300 — intervention group
Group type: COMPARATOR
Intervention: Tirofiban
Number of subjects: 0
Study 23790741 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT) for 8 weeks
Number of subjects: 23
Study 23790741 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 23
Study 23790741 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 23
Study 21464426 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon β‐1b 250 μg
Number of subjects: 2244
Study 21464426 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon β‐1b 500 μg
Number of subjects: 2244
Study 21464426 — intervention group
Group type: COMPARATOR
Intervention: Glatiramer acetate (GA)
Number of subjects: 2244
Study 20128320 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Advanced Clean dentifrice (0.3% triclosan, 2% copolymer, dual phase silica)
Number of subjects: 144
Study 20128320 — intervention group
Group type: COMPARATOR
Intervention: Colgate Total Advanced Clean (control)
Number of subjects: 144
Study 17059386 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised Phase III trials
Number of subjects: 3700
Study 17059386 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected Phase I and II studies
Number of subjects: 3700
Study 17059386 — intervention group
Group type: EXPERIMENTAL
Intervention: Interesting studies on hot topics
Number of subjects: 3700
Study 15448446 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 sacroiliac screw in the vertebral body of S1
Number of subjects: 12
Study 15448446 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 screws convergingly in S1
Number of subjects: 12
Study 15448446 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 screw in S1 and 1 in S2
Number of subjects: 12
Study 11457627 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-session group intervention focused on strategies for practicing safer sexual behavior
Number of subjects: 332
Study 11457627 — intervention group
Group type: COMPARATOR
Intervention: Five-session, contact-matched, health-maintenance support group (standard-of-care comparison)
Number of subjects: 332
Study 11457627 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral risk-reduction intervention group
Number of subjects: 332
Study 9893539 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tramadol 1 mg.kg‐1 (T1)
Number of subjects: 88
Study 9893539 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tramadol 2 mg.kg‐1 (T2)
Number of subjects: 88
Study 9893539 — intervention group
Group type: COMPARATOR
Intervention: Intravenous pethidine 1 mg.kg‐1 (PE)
Number of subjects: 88
Study 9893539 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 88
Study 8008364 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative suture adjustment
Number of subjects: 25
Study 8008364 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intraoperative suture adjustment)
Number of subjects: 25
Study 2646257 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 218
Study 2646257 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus hyperthermia (RT + HT)
Number of subjects: 218
Study 2646257 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + HT in lesions less than 3 cm
Number of subjects: 218
Study 2646257 — intervention group
Group type: COMPARATOR
Intervention: RT alone in lesions less than 3 cm
Number of subjects: 218
Study 2646257 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + HT in breast lesions
Number of subjects: 218
Study 2646257 — intervention group
Group type: COMPARATOR
Intervention: RT alone in breast lesions
Number of subjects: 218
Study 2646257 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + HT in trunk and extremities lesions
Number of subjects: 218
Study 2646257 — intervention group
Group type: COMPARATOR
Intervention: RT alone in trunk and extremities lesions
Number of subjects: 218
Study 2646257 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + HT in lesions larger than 3 cm
Number of subjects: 218
Study 2646257 — intervention group
Group type: COMPARATOR
Intervention: RT alone in lesions larger than 3 cm
Number of subjects: 218
Study 4606495 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin and tetracycline (group 2)
Number of subjects: 196
Study 4606495 — intervention group
Group type: COMPARATOR
Intervention: Neomycin (group 1)
Number of subjects: 196
Study 4606495 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group 3)
Number of subjects: 196
Study 29169902 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTIVA'T group (nutritional and physical activity ≥5h/wk intervention)
Number of subjects: 96
Study 29169902 — intervention group
Group type: COMPARATOR
Intervention: Control group (nutritional intervention and ≤3h/wk physical activity)
Number of subjects: 96
Study 29267375 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard versus New Antiepileptic Drugs (SANAD) treatment
Number of subjects: 0
Study 26648705 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific strength training group
Number of subjects: 60
Study 26648705 — intervention group
Group type: COMPARATOR
Intervention: Usual PR program group
Number of subjects: 60
Study 23390177 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum stimulation (Cefaly, STX‐Med., Herstal, Belgium) applied daily for 20 minutes for 3 months
Number of subjects: 67
Study 23390177 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 67
Study 23390177 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum stimulation
Number of subjects: 67
Study 22005160 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid initiation of quetiapine (up to 800 mg/d by Day 4)
Number of subjects: 40
Study 22005160 — intervention group
Group type: COMPARATOR
Intervention: Conventional initiation of quetiapine (up to 400 mg/d by Day 5)
Number of subjects: 40
Study 19200399 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised multi-modal exercise therapy programme
Number of subjects: 224
Study 19200399 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised manual therapy programme
Number of subjects: 224
Study 19200399 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercise therapy and manual therapy
Number of subjects: 224
Study 19200399 — intervention group
Group type: COMPARATOR
Intervention: No trial physiotherapy (control)
Number of subjects: 224
Study 19200399 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (control)
Number of subjects: 224
Study 16970536 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexion Distraction
Number of subjects: 235
Study 16970536 — intervention group
Group type: COMPARATOR
Intervention: Exercise Program
Number of subjects: 235
Study 15164336 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg diet (640 mg/d additional dietary cholesterol)
Number of subjects: 52
Study 15164336 — intervention group
Group type: COMPARATOR
Intervention: Placebo diet (0 mg/d additional dietary cholesterol)
Number of subjects: 52
Study 11240880 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 1-2 mg.kg-1
Number of subjects: 21